Objectives. The authors used a meta-analytic technique to (1) quantify the evidence of an association between duration of breastfeeding and risk of childhood acute lymphoblastic leukemia (ALL) or acute myeloblastic leukemia (AML), (2) assess the influence of socioeconomic status (SES) on any such associations, and (3) discuss the implications of these findings for the evaluation of whether breastfeeding reduces the risk of childhood leukemia.
Leukemia is the leading cause of cancer morbidity among children younger than 15 years of age in the United States. 1 Data from the Surveillance, Epidemiology, and End Results (SEER) registry suggest that acute lymphoblastic leukemia (ALL) accounted for 78% of all childhood leukemia cases diagnosed in the U.S. from 1975 through 1995, while acute myeloid leukemia (AML) accounted for 16%. 1 Incidence among children younger than 15 years of age showed a modest increase from 1975 through the late 1980s but decreased slightly from 1989 to 1999. 2 Currently, the causes of childhood ALL are not well known, although sex, age, race, in utero ionizing radiation, and specific genetic syndromes have been consistently shown to be associated with risk for ALL. 1 As for childhood AML, chemotherapeutic agents and in utero and postnatal ionizing radiation are recognized risk factors, and an association has been elucidated between race and risk of childhood AML. 1 Because ALL encompasses a heterogeneous group of molecular subtypes, independent examination of etiologic and epidemiologic factors is required for each subtype. 3, 4 Furthermore, the clinical presentation of these molecular subtypes is also quite varied. 3 A possible infectious etiology for the major subtype of ALL has been suggested by Greaves, 3 who hypothesized that c-ALL (common B-cell precursor ALL) arises as a consequence of a rare, abnormal response to a nonspecific common infection. Two separate genetic events may lead to the presentation of c-ALL: an initial spontaneous event during the expansion of B-cell precursors pre-or perinatally and a subsequent event in the same mutant clone following antigenic challenge early in life (e.g., exposure to a common, nonspecific infection and the resulting stimulation of the young child's underdeveloped immune system). Support for this hypothesis is seen in genetic backtracking of the preleukemic clone TEL-AML1, a genetic determinant of c-ALL, using newborn blood spots. 4 Speculation has focused recently on the role of breastfeeding in protecting children from disease. 3, 5, 6 Human milk has long been recognized as providing numerous antimicrobial, anti-inflammatory, and immunomodulating agents. Many studies have shown conclusively that breastfeeding protects against acute gastrointestinal infections through transmission of maternal antibodies, macrophages, and lymphocytes. 7, 8 In contrast, the evidence for the protective effect of breastfeeding with regard to acute respiratory infection is still under debate. 8, 9 Therefore, since breast milk contains many beneficial biological factors, the Greaves hypothesis implies that breastfeeding mediates the occurrence of childhood ALL as a result of a rare, abnormal response to a common infection. 1 To date, no similar mechanism has been suggested for the association of breastfeeding and childhood AML.
The scientific evidence has been mixed regarding the association of breastfeeding with childhood leukemia. A number of studies have shown no association between breastfeeding and leukemia risk. [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] Five recent case-control studies, however, have suggested that breastfeeding protects children from developing childhood ALL. 6, [24] [25] [26] [27] The largest of these studies 24 included more than 1,700 ALL cases, while the smallest study 27 included only 69 cases. In addition to varying samples sizes, these five studies differed on methods of case ascertainment and selection of controls, and in measurement of breastfeeding duration. More important, two out of the five studies 25, 27 did not adjust for any marker of socioeconomic status (SES). This lack of adjustment in the statistical analysis is unusual since measures of SES, particularly maternal education, have been shown to be highly associated with breastfeeding. 28 As for the association of SES with risk of childhood leukemia, results have varied. Early ecologic and descriptive studies in the United States suggested that higher SES was a possible risk factor for childhood leukemia, but in contrast, case-control studies have reported lower SES in childhood leukemia patients compared to control subjects. 29 The above issues prompt the need for a thorough review of the current literature on breastfeeding and childhood leukemia. For this study, we used a meta-analytic approach to evaluate the association of maternal breastfeeding with the risk of childhood leukemia. To our knowledge, this is the first report to systematically review epidemiologic data on this topic and to present risk estimates for childhood ALL and AML associated with breastfeeding. Our goals were (1) to quantify any association between duration of breastfeeding and risk of childhood ALL or AML, (2) to assess the influence of SES on any such associations, and (3) to discuss the implications of these findings for the evaluation of whether breastfeeding reduces the risk of childhood leukemia.
METHODS
We searched MEDLINE and CancerLit for original research and review articles on childhood leukemia and breastfeeding. In addition, we reviewed the bibliographies in these publications as well as master's theses and PhD dissertations filed electronically that addressed breastfeeding and childhood leukemia. Keyword combinations for the online searches consisted of "breastfeeding and childhood cancer," "breastfeeding and childhood leukemia," "infant feeding and childhood leukemia," "infant feeding and childhood cancer," "infant feeding and cancer," and the names of three prominent investigators in the field of maternal and child health whose names were encountered in the initial literature search.
Thirty articles were initially identified. Studies that presented data on any type of leukemia in children 15 years or younger in terms of an odds ratio (OR) and confidence interval (CI) and analyzed duration of breastfeeding in months were selected for the analysis. Seventeen studies were excluded, leaving 14 for the analysis. 6, [10] [11] [12] [13] 15, 17, [19] [20] [21] [24] [25] [26] 30 Three of these studies were not peer-reviewed. 10, 11, 21 Of the 17 excluded articles, two reported no ORs, 31, 32 one reported no CIs or p-values, 33 two reported ORs only for all cancers combined, 34, 35 three were duplicate reports, [36] [37] [38] two were topical reviews on breastfeeding, 9,39 one was a literature review, 5 and four did not analyze breastfeeding duration. 14, 16, 18, 27 Finally, two cohort studies did not satisfy the selection criteria: one did not report any quantitative results 22 while the other did not analyze breastfeeding duration. Table 1 outlines important characteristics of the studies included in the meta-analysis. First, eight of the 14 studies excluded cases of leukemia in infants (usually children younger than 1 year of age) to avoid possible biases associ- ated with premature cessation of breastfeeding in children with cancer and also because most leukemias occurring during infancy are known to have different etiologies from childhood leukemias. 40 We divided the 14 studies into subgroups based on the leukemia classifications used. The ALL classification was generally straightforward, with only one study specifying "leukemia" instead of "ALL." 25 Since the majority of childhood leukemia is ALL, 1 we included this study in the ALL group. Four studies 6, 12, 13, 30 used the classifications "other leukemias" or acute non-lymphoblastic leukemia (ANLL) instead of AML. Nevertheless, we included these studies in the AML group since the majority of such cases are AML cases. 1 Finally, for purposes of this meta-analysis, we classified breastfeeding for six months or less as shortterm breastfeeding, and breastfeeding for more than six months as long-term breastfeeding.
For each of the 14 articles reviewed, an OR and its 95% CI were extracted. When available, ORs adjusted for SES were selected since SES was the most widely used potential confounder in these studies. A fixed effects model based on the general principles of Greenland 41 was utilized since this model maintains a direct relationship between sample size and relative weight among smaller studies, unlike a random effects model. 42 In addition, a fixed effects model, in contrast to a random effects model, assumes no heterogeneity between studies. 41 Each OR was assigned a weight (W i ) equal to the inverse square of its standard error (SE): W i ϭ1/(SE) 2 . SEs were calculated by dividing the natural log of the ratio of the upper and lower 95% confidence limits (CLs) by 3.92: SEϭln(CL upper /CL lower )/3.92. For each study, the weight was multiplied by the natural log of the risk ratio (b i ) to give a summary measure (W i b i ). A combined summary was calculated by adding the summary measures and dividing by the sum of the weights: bϭSW i b i /SW i . A summary OR was produced by taking the exponential of the combined summary: OR sum ϭexp b . Heterogeneity among study results was assessed using the Chi-square statistic:
2 . When evidence of heterogeneity was present, the 95% CI of the summary OR was readjusted using new weights based on a random effects model that incorporated between-study heterogeneity. 43 Finally, publication bias, the tendency of journals to publish only those studies reporting significant associations, was evaluated visually by using the traditional funnel graph method to display the distribution of all included studies by their point estimates and SEs. 44 Smaller studies will naturally be less precise (have larger SEs), and therefore, by chance, the risk estimates will vary around the true point estimate to a greater extent than in larger studies. As demonstrated by Light and Pillemer, a symmetric funnel shape is formed when study results and sample sizes are plotted if no publication bias is present. 44 If bias is present, the shape of the graph is skewed, indicating a correlation between point estimates and their SEs. In addition, as recommended by Begg and Mazumdar, we performed rank correlation tests to test for a significant relationship between the sample sizes and effect sizes of the studies. 45 If a significant correlation does exist between these two factors, then publication bias is considered to be present.
RESULTS
The 14 articles on breastfeeding and childhood leukemia contributed 6,835 ALL cases and 1,216 AML cases. No evidence of publication bias was apparent for studies reporting results on the association between long-term breastfeeding and risk of ALL since the data points for these studies were fairly randomly distributed around the combined OR estimate (Figure 1 ) and the p-value for the rank correlation tests was nonsignificant (pϭ0.58). Similarly, we found no evidence of publication bias for studies exploring the association between long-term breastfeeding and risk of AML (not shown, pϭ0. 46) .
As shown in Tables 2 and 3 , a significant, negative association was observed between short-term breastfeeding and ALL (ORϭ0.88; 95% CI 0.80, 0.96), but the AML results (ORϭ0.90; 95% CI 0.80, 1.02) were not significant. Tables 2  and 3 and Figures 2 and 3 show a significant, negative association between long-term breastfeeding and ALL based on 14 studies (ORϭ0.76; 95% CI 0.68, 0.84) and a significant, negative association between long-term breastfeeding and AML based on eight studies (ORϭ0.85; 95% CI 0.73, 0.98). Heterogeneity statistics for leukemia types and duration of breastfeeding were not significant (p-values ranged from 0.13 to 0.28) except for the ALL analysis addressing shortterm breastfeeding (pϭ0.03). For this point estimate, the adjusted 95% CI (0.80, 0.97) was almost exactly the same as the unadjusted 95% CI (0.80, 0.96). Therefore, use of the fixed effects model, which assumes no heterogeneity among studies, was appropriate. A random effects model yielded similar ORs and heterogeneity statistics (not shown). Overall, the combined ORs for all 14 studies supported a protective role for breastfeeding with regard to the risk of childhood leukemia.
Separate analyses were also conducted that addressed the association of breastfeeding duration with risk of ALL or AML using data adjusted and not adjusted for SES (Tables 2  and 3 ). The ORs for short-term breastfeeding and risk of ALL based on adjusted and unadjusted data were both in the protective direction, analogous to the OR for the 14 studies combined. For long-term breastfeeding and ALL, the ORs based on adjusted and unadjusted data were similar to the OR for the combined studies, although breastfeeding was no longer significantly protective in the unadjusted data (OR unadjusted ϭ0.78; 95% CI 0.55, 1.10). For the AML studies, the ORs for short-term breastfeeding based on adjusted and unadjusted data were both suggestive of a protective effect, similar to the OR for the combined studies. For long-term breastfeeding and risk of AML, the ORs for adjusted and unadjusted data were comparable to the OR for combined data, although breastfeeding was no longer significantly protective in the unadjusted data (OR unadjusted ϭ0.89, 95% CI 0.29, 2.71). The estimates for the unadjusted AML data should be interpreted with caution since only two studies were available for comparison. Table 4 shows the ORs for SES-adjusted data from the meta-analysis, as well as separately for the United Kingdom Childhood Cancer Study (UKCCS) and the Children's Cancer Group (CCG) study. 19, 24 Overall, SES as a potential confounder appeared to play no substantial role in the findings of either the short-term or long-term breastfeeding studies. Tables 2 and 3 also display the weights applied to each study result in the meta-analysis. An important point to note is that the weights are directly related to the SE for each study (see Methods), but the SE does not always correlate with sample size-the SE depends on both the number of individuals in the study and the distribution of these individuals across exposure and disease categories. For ALL, no study contributed more than 34% of the total weight for long-term breastfeeding or more than 32% of the total weight for short-term breastfeeding. For AML, the UKCCS 19 contributed 74% of the total weight for long-term breastfeeding and 70% of the total weight for short-term breastfeeding. Removal of this study from the AML analysis resulted in an OR of 0.73 (95% CI 0.55, 0.97) for long-term breastfeeding and an OR of 0.91 (95% CI 0.73, 1.15) for short-term breastfeeding. Thus, exclusion of this study produced a moderate decrease in the combined OR and a wider CI for long-term breastfeeding, and essentially no change in the combined OR and a wider CI for short-term breastfeeding.
DISCUSSION
This meta-analysis supports the hypothesis that short-and long-term breastfeeding play a protective role with regard to the risk for ALL. In addition-and not anticipated on biological grounds-the results show that long-term breastfeeding is also protective against AML. However, while the classification of ALL was fairly uniform across studies, the AML category was more variable. The variability in AML classification could lead to misclassification of the outcome and subsequent spurious associations. Furthermore, inclusion of SES as a potential confounder had minimal influence on the risk estimates for both short-term and long-term breastfeeding for ALL and AML. Before any general conclusions can be drawn, several issues must be considered: the results of the two largest case-control studies in the metaanalysis, 19 ,24 the results of the two cohort studies, 22,23 current knowledge regarding the etiology of ALL and AML, the relationship between SES and breastfeeding, and the effect of differential participation rates for case and control samples that differed in SES.
The UKCCS 19 and CCG study 24 were the two largest and/ or most influential studies in the meta-analysis. The UKCCS included 1,401 (87%) ALL and 214 (13%) AML case patients recruited from health programs that enrolled 98% of the total UK population; control subjects were selected from population-based health rosters. In contrast, the CCG study included 1,744 (79%) ALL and 456 (21%) AML case patients enrolled from specific CCG centers, and control subjects were selected via random-digit-dialing (RDD). The use of RDD in control recruitment introduces a concern regarding unknown and possibly stronger SES differentials between cases and controls, a major issue when conducting a case-control study. Both studies found that long-term breast-feeding was protective for ALL, but the CI for the risk estimate from the UKCCS did not exclude unity (1.00), whereas the CI for the risk estimate reported by the CCG study clearly excluded unity (1.00), indicating statistical significance. The UKCCS, however, found no association between short-or long-term breastfeeding and risk of AML, while the CCG study found a significant protective effect of long-term breastfeeding for AML. The UKCCS investigators were cautious in drawing conclusions due to a concern about systematic bias resulting from documented differences in participation between cases and controls. The CCG study investigators were less tenuous in their conclusion that the results of their study demonstrated lower risk of ALL and AML for breastfed infants, particularly those breastfed for more than six months. Two large cohort studies have been published, one evaluating the association between breastfeeding and risk of childhood cancer 22 and the other evaluating the association between breastfeeding and risk of childhood ALL. 23 The major advantage of cohort studies is that they are not subject to the same biases as case-control studies and can better assess the temporal relationship between exposure and disease. 22 Thirty-three cancer cases, nine of which were leukemia cases, were identified from death certificates, through the Cancer Registration system, or from follow-up interviews conducted at ages 5 and 10 years. No childhood cancer data are presented by the investigators, but breastfeeding was reported to not be protective for childhood cancer. Although the Golding et al. study is not as informative as the study by Murray et al., these cohort studies indicate the lack of a protective effect of breastfeeding on risk of childhood ALL or childhood cancer.
The observation of a protective effect of breastfeeding for both ALL and AML in our analyses raises questions about the classification of leukemia cases in the two subgroups as well as the underlying biological mechanism involved. First, four studies included in this meta-analysis specified ANLL or "other leukemias" rather than AML ex- plicitly. 6, 12, 13, 30 Therefore, this group of leukemias might not be as homogeneous as the ALL group, thus constraining inferences regarding AML and breastfeeding. Second, Greaves's hypothesis of an abnormal immunological response leading to presentation with childhood leukemia is specific for the natural history of c-ALL. ALL and AML have different cell origins: childhood ALL arises from lymphoid stem cells while childhood AML arises from myeloid stem cells. 46 If breastfeeding modulates the immune response via B-cell precursors, as the Greaves hypothesis suggests, then the protective effect observed for AML is unexpected. Our results imply that a separate immunological mechanism is operating via myeloid precursors along with the mechanism suggested by Greaves. It is recognized that higher SES mothers have higher rates of breastfeeding than lower SES mothers, and this pattern has been stable over the past two decades. 47, 48 Higher SES mothers tend to retrospectively recall longer periods of breastfeeding than lower SES mothers. 49 Variations in breastfeeding practices may reflect differences in education, a measure of SES. If the mother is better educated about the benefits of breast milk, she may be more inclined to breastfeed her child. 28 In addition, lower SES mothers may qualify for government food support programs that can help pay for infant formula, and the availability of food assistance for the family may deter the mother from breastfeeding her infant children. 50 Finally, the roles of SES and participation bias can be assessed in this body of literature. In both the UKCCS 19 and CCG study, 24 the control subjects were of higher SES than the case patients. Even though SES was adjusted for in both of these studies (the UKCCS adjusted for a deprivation index, and the CCG study adjusted for maternal education and family annual income), this factor could have introduced some residual bias. The most important consideration is the representativeness of the controls relative to the base population from which the cases arise. This can best be assessed with the population-based design of studies such as the UKCCS.
The effect of differential participation rates between cases and controls on the overall results is important to consider. For example, when the UKCCS analysis was published, 19 the authors cited a meta-analysis that demonstrated a protective role of breastfeeding with respect to risk of diabetes mellitus; however, the controls had higher participation rates than the cases. 51 In the current meta-analysis, participation rates 52 could be calculated for only six of the 14 included studies. 10, 15, [19] [20] [21] 26 For five of these six studies, 10, 15, 19, 21, 26 the participation rates for cases were higher than those for controls, and in most of these studies, the controls were of higher SES than the cases. Therefore, the association of breastfeeding with SES in combination with differential participation rates by SES could have biased the OR toward a protective effect. This meta-analysis demonstrated a protective association between breastfeeding and risk of childhood ALL and possibly AML. Three alternative explanations must be considered. First, a systematic bias may be present in case-control studies of childhood leukemia arising from differential participation rates for case and control samples that differed in SES. Second, the effect on ALL risk may be spurious, as suggested by the results of the two cohort studies; 22, 23 unfortunately, these studies provided no information regarding AML. Third, the protective effect of breastfeeding may not be limited to ALL, as predicted by the Greaves hypothesis; however, support for a different underlying mechanism for AML would rely on an accurate and homogeneous category of AML cases. Further evaluation of the biological mechanisms while taking into consideration potential biases can be feasibly achieved with more large-scale case-control studies utilizing population-based, SES-matched controls.
In conclusion, the potential protective effect of breastfeeding on risk of childhood ALL may be more complicated than the current literature suggests. Nevertheless, the available evidence suggests that such a protective effect exists for both ALL and AML, with the caveats noted. 
